Expression cloning of functional receptor used by SARS coronavirus.
about
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria MarburgvirusCD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirusTMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike proteinMolecular mechanisms of severe acute respiratory syndrome (SARS)The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterizationEzrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stageProteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein.Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.In vitro and in vivo studies identify important features of dengue virus pr-E protein interactionsIdentification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike proteinRecombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cellsIdentification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.Emerging respiratory viruses: challenges and vaccine strategiesEvidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.Molecular pathology in the lungs of severe acute respiratory syndrome patients.Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARSDifference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challengeHosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion.Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.Losartan and enalapril decrease viral absorption and interleukin 1 beta production by macrophages in an experimental dengue virus infection.Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors.Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS).Severe acute respiratory syndromeRetroviral Pseudotypes - From Scientific Tools to Clinical Utility
P2860
Q24301153-EF90960F-2A07-419A-A636-45BB83798540Q24307914-74231353-4573-4E96-AD9D-1038A7BC8781Q24339582-24D9FE71-AFBA-4535-A159-2C931F6815FAQ24799739-1C29241B-B402-4AA6-B4EE-B7D6694417E5Q24817089-FA54A997-A6AC-4559-8BE6-F9A8E46A23E7Q27335547-6329B5B3-6D0C-41F9-A4EF-FE6CEA624448Q30354466-144E0EC4-D2EB-4506-B47E-5C25E1A51DC1Q30360085-D46FCFEA-B364-4218-881A-A3842C0EF89BQ33516234-804725BB-CBEE-41F6-A829-111148F7066BQ33529338-E8C448F9-DB96-4AF5-A364-5521DDB0E6D6Q33558501-DE311F87-1428-4DF4-B60C-05E5803EE888Q33727990-96A42511-E61D-4E1C-9352-45812CA2ABCCQ33788831-C34941A4-96A4-4179-AAB0-24162D3274AFQ33834543-EE9D5F31-6789-44C0-8348-65FF3B6A0010Q33841118-4A4B1540-7DA8-455B-B875-14A4939D9D79Q33908658-2CA2C239-8AC7-4C14-B00C-17ECE1013CDCQ34438091-38CCC913-C07F-4709-B569-225633E0EDB1Q34983662-352AB3B9-5DBB-4866-89C2-BFBC17B3F1C6Q35070868-83A0BE4C-2F7F-4008-9CF3-DEF8F0700AB7Q35076795-BE513148-C58E-46C2-AEB9-81722887D2FEQ35750156-55452538-17F6-4E8B-A648-F0039444335EQ35817398-DF3BD07B-E99E-4440-8961-C17ECDD7212FQ35946920-1BD24730-C455-4857-BDA4-8EB2569DDD7CQ36483269-6A431600-8AF7-4353-BFB5-395B4184B5D8Q36498144-778D0B11-42CF-41D7-B667-5454860AA44DQ36520754-317A2817-3D2F-4612-A012-476F3AB76933Q36972346-74B03636-9292-4053-ADF5-00A30749A65DQ37183997-5C4294E1-9882-458F-8E9D-C41BE4A45751Q37511480-605D7086-CBA5-4CC9-B511-993801323AF4Q39571113-C6752B11-8C64-40ED-BE2F-784101E7A521Q39992400-214D802C-F708-4595-9507-5E4A825715F7Q40141350-78F2EE76-7B5D-4CE3-8C9E-0DA5A4776170Q40243132-050CC572-7229-4B51-BB04-5954D96E1B79Q40404194-5CFB5690-5FE7-4813-85FF-CF8D3B0BCFF3Q40817818-86F9D764-DF69-47FF-82ED-AC1573BD1CDDQ43218942-1F79BC35-2330-493C-A39F-82F9DD13C683Q44289899-C3880A9B-127A-40A8-838E-3F0F27E3EACFQ56775278-7DBF2888-D369-4FF8-BE6D-237302961321Q58382398-07D96A5F-6C83-463E-A949-C8CA6B449CFC
P2860
Expression cloning of functional receptor used by SARS coronavirus.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression cloning of functional receptor used by SARS coronavirus.
@ast
Expression cloning of functional receptor used by SARS coronavirus.
@en
type
label
Expression cloning of functional receptor used by SARS coronavirus.
@ast
Expression cloning of functional receptor used by SARS coronavirus.
@en
prefLabel
Expression cloning of functional receptor used by SARS coronavirus.
@ast
Expression cloning of functional receptor used by SARS coronavirus.
@en
P2093
P1476
Expression cloning of functional receptor used by SARS coronavirus.
@en
P2093
Aihua Zheng
Guangwen Wang
Hongkui Deng
Huijun Liu
Mingxiao Ding
Tingting Qing
P304
P356
10.1016/J.BBRC.2004.01.076
P407
P50
P577
2004-03-01T00:00:00Z